- Sections
- C - Chimiemétallurgie
- C08B - Polysaccharidesleurs dérivés
- C08B 37/04 - Acide alginiqueSes dérivés
Détention brevets de la classe C08B 37/04
Brevets de cette classe: 116
Historique des publications depuis 10 ans
3
|
2
|
8
|
13
|
4
|
13
|
4
|
9
|
4
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Mochida Pharmaceutical Co., Ltd. | 337 |
14 |
Sigilon Therapeutics, Inc. | 103 |
6 |
Seikagaku Corporation | 186 |
4 |
The University of Tokyo | 4176 |
4 |
Dainichiseika Color & Chemicals Mfg. Co., Ltd. | 371 |
3 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 823 |
3 |
Nuecology Biomedical Inc. | 14 |
3 |
Massachusetts Institute of Technology | 10057 |
2 |
Adocia | 142 |
2 |
Children's Medical Center Corporation | 1868 |
2 |
FMC Biopolymer AS | 23 |
2 |
Osaka University | 3376 |
2 |
Shanghai Green Valley Pharmaceutical Co., Ltd. | 33 |
2 |
Universidad Del Pais VASCO | 80 |
2 |
The University of North Carolina at Chapel Hill | 2033 |
2 |
Matripharm International Inc. | 10 |
2 |
Qingdao Bright Moon Seaweed Group | 3 |
2 |
Kao Corporation | 4964 |
1 |
Daikin Industries, Ltd. | 9995 |
1 |
The Johns Hopkins University | 5667 |
1 |
Autres propriétaires | 56 |